HR 1230 · 111th Congress 2009–2011, ended

To amend the Public Health Service Act to provide for research on acquired bone marrow failure diseases, minority-focused programs on such diseases, and the development of best practices for diagnosis of and care for individuals with such diseases.

Latest action · Nov 15, 2010 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 26, 2009
  2. Passed HouseSep 30, 2010
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to conduct research on acquired bone marrow failure diseases, which may address factors including: (1) trends in the characteristics of individuals who are diagnosed with such diseases, including age, race and ethnicity, general geographic location, sex, and family history; (2) the genetic and environmental factors, including exposure to toxins, that may be associated with developing such diseases; (3) approaches to treating such diseases; and (4) outcomes for individuals treated for such diseases, including outcomes for recipients of stem cell therapeutic products.

Authorizes the Secretary to collaborate with the Radiation Injury Treatment Network of the C.W. Bill Young Cell Transplantation Program to: (1) augment data for studies; (2) access technical assistance that may be provided by the Network; or (3) perform joint research projects.

(Sec. 3) Authorizes the Secretary to establish and coordinate outreach and informational programs targeted to minority populations, including Hispanic, Asian-American, Native Hawaiian, and Pacific Islander populations, that are affected by acquired bone marrow failure diseases. Includes among program activities: (1) making information about treatment options and clinical trials for such diseases publicly available; and (2) providing referral services for treatment options and clinical trials.

(Sec. 4) Authorizes the Secretary, acting through the Director of the Agency for Healthcare Research and Quality, to award grants to researchers to study best practices with respect to diagnosing acquired bone marrow failure diseases and providing care to individuals with such diseases.

Cosponsors 62

Members who signed on, in the order they did. Signatures ran from Feb 26, 2009 to Sep 14, 2010; 19 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-PAAllyson Y. SchwartzOriginalFeb 26, 2009
D-CAAnna G. EshooOriginalFeb 26, 2009
D-MABarney FrankOriginalFeb 26, 2009
D-MDChris Van HollenOriginalFeb 26, 2009
D-CODiana DeGetteOriginalFeb 26, 2009
R-VAFrank R. WolfOriginalFeb 26, 2009
D-TXGene GreenOriginalFeb 26, 2009
D-MAJames P. McGovernOriginalFeb 26, 2009
D-WAJim McDermottOriginalFeb 26, 2009
R-MOJo Ann EmersonOriginalFeb 26, 2009
D-MIJohn Conyers, Jr.OriginalFeb 26, 2009
D-GAJohn LewisOriginalFeb 26, 2009
D-PAJohn P. MurthaOriginalFeb 26, 2009
D-GUMadeleine Z. BordalloOriginalFeb 26, 2009
D-HIMazie K. HironoOriginalFeb 26, 2009

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Feb 26, 2009Markup Sep 23, 2010Reported Sep 28, 2010
Health Subcommittee
Referred Mar 6, 2009Hearings Sep 15, 2010Markup Sep 16, 2010Reported Sep 16, 2010
SenateHealth, Education, Labor, and Pensions Committee
Referred Nov 15, 2010

Actions 19

Everything that happened, newest first.

  1. Nov 15, 2010Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Sep 30, 2010Considered as unfinished business. (consideration: CR H7380)
  3. Sep 30, 2010Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 9/28/2010 H7193)
  4. Sep 30, 2010Motion to reconsider laid on the table Agreed to without objection.
  5. Sep 30, 2010The title of the measure was amended. Agreed to without objection.
  6. Sep 28, 2010Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-637.
  7. Sep 28, 2010Placed on the Union Calendar, Calendar No. 377.
  8. Sep 28, 2010Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  9. Sep 28, 2010Considered under suspension of the rules. (consideration: CR H7193-7194)
  10. Sep 28, 2010DEBATE - The House proceeded with forty minutes of debate on H.R. 1230.
  11. Sep 28, 2010At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.
  12. Sep 23, 2010Committee Consideration and Mark-up Session Held.
  13. Sep 23, 2010Ordered to be Reported (Amended) by Voice Vote.
  14. Sep 16, 2010Subcommittee Consideration and Mark-up Session Held.
  15. Sep 16, 2010Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  16. Sep 15, 2010Subcommittee Hearings Held.
  17. Mar 6, 2009Referred to the Subcommittee on Health.
  18. Feb 26, 2009Introduced in House
  19. Feb 26, 2009Referred to the House Committee on Energy and Commerce.

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
House · ExtensionsDebate and remarks E1849, H7380Doris O. Matsui D-CASep 29, 2010
HouseDebate and remarks H7193Text printed H7193Frank Pallone, Jr. D-NJ, Michael C. Burgess R-TXSep 28, 2010
ExtensionsDebate and remarks E2584Candice S. Miller R-MIOct 20, 2009

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimates 2

  1. Sep 27, 2010H.R. 1230, Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010<p>Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on September 23, 2010</p>
  2. Sep 27, 2010H.R. 1230, Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on September 23, 2010

Printed hearings 4

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 111-154PENDING PUBLIC HEALTH LEGISLATION73 pagesEnergy and Commerce CommitteeSep 15, 2010
S. Hrg. 111-666U.S. VIRGIN ISLANDS, REPUBLIC OF THE MARSHALL ISLANDS, PUERTO RICO, AND POLITICAL STATUS PUBLIC EDUCATION PROGRAMS136 pagesEnergy and Natural Resources CommitteeMay 19, 2010
Serial No. 111-26H.R. 2499, ``PUERTO RICO DEMOCRACY ACT OF 2009''93 pagesNatural Resources CommitteeJun 24, 2009
—DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR 20101,009 pagesAppropriations CommitteeMar 18, 2009–May 12, 2009

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Public Health Service Act to provide for the establishment of a National Acquired Bone Marrow Failure Disease Registry, to authorize research on acquired bone marrow failure diseases, and for other purposes.
Official Titles as Amended by House
To amend the Public Health Service Act to provide for research on acquired bone marrow failure diseases, minority-focused programs on such diseases, and the development of best practices for diagnosis of and care for individuals with such diseases.
Short Titles as Introduced
Bone Marrow Failure Disease Research and Treatment Act of 2009
Short Titles as Reported to House
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. Nov 15, 2010Referred in Senate
  2. Oct 1, 2010Engrossed in House
  3. Sep 28, 2010Reported in House
  4. Feb 26, 2009Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.